The cost of diagnosing dementia in a community setting

被引:15
作者
Jedenius, Erik [1 ]
Wimo, Anders [1 ,2 ]
Stromqvist, Jan [3 ]
Jonsson, Linus [4 ]
Andreasen, Niels [1 ]
机构
[1] Alzheimers Dis Res Ctr, Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Stockholm, Sweden
[2] Ageing Res Ctr, Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Stockholm, Sweden
[3] Kalmar Cty Council, Primary Care Unit, Kalmar, Sweden
[4] Innovus, Stockholm, Sweden
关键词
Alzheimer's disease; dementia; health economics; general practitioner; family practices; dementia nurse; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PRIMARY-CARE;
D O I
10.1002/gps.2365
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: In order to cope with the increasing number of individuals with dementia, it is crucial to develop the diagnostic capacity in primary care in cooperation with dementia specialists. Further, in order to establish prerequisites for care and planning it is important to identify the cost of dementia diagnosis. This study aims to evaluate the cost of establishing a dementia diagnosis. Methods: This is a prospective, time- and resource utilization study for the identification of the total cost associated with diagnosing dementia (from start of the diagnostic process to time for established or rejected dementia diagnosis) both at the specialist and primary care level. Results: Dementia evaluation in primary care took between 2 weeks and 2 months before reaching diagnosis. The average cost for all patients evaluated at the primary care level was 477 Euro ((sic)), whereas evaluations done on a specialist level reached a cost of 1115 (sic). Thus, the costs per true diagnosed case consist of the cost for all dementia investigations divided by the number of finalized diagnoses. Conclusions: In this study the cost for diagnosing dementia per true diagnosed patient is 849 (sic) at the primary care level and 1334 (sic) at the specialist level. Based on this result we estimated that the cost of establishing a dementia diagnosis is 1% of the total cost of dementia. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:476 / 482
页数:7
相关论文
共 20 条
[1]   CSF biomarkers for mild cognitive impairment and early Alzheimer's disease [J].
Andreasen, N ;
Blennow, K .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (03) :165-173
[2]  
ASTRAND R, 2007, SYMPTOM ENKAT
[3]  
Engedal Knut, 2002, Tidsskr Nor Laegeforen, V122, P520
[4]   THE MEANING OF COGNITIVE IMPAIRMENT IN THE ELDERLY [J].
FOLSTEIN, M ;
ANTHONY, JC ;
PARHAD, I ;
DUFFY, B ;
GRUENBERG, EM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1985, 33 (04) :228-235
[5]  
Giacobini E, 2000, ANN NY ACAD SCI, V920, P321
[6]  
Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37
[7]   An evaluation of dementia screening in the primary care setting [J].
Harvan, Jennifer R. ;
Cotter, Valerie T. .
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2006, 18 (08) :351-360
[8]  
JEDENIUS E, 2008, SCAND J PRIM HEALTH, V26, P1
[9]  
Jurkowski C.A., 1998, AM J MED, V104, p39S
[10]  
Jurkowski Claire L., 1998, American Journal of Medicine, V104, p13S, DOI 10.1016/S0002-9343(98)00023-0